Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Biotechnology

Healthcare
$18.31 +0.58%

+$0.10 today

Market cap
$980.14M
Beta
0.00
52W Low $14.85High $23.00

Volume 0.68M

Average 0.41M

SPTX Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

No reported Retained Earnings figures are available to summarize.

Retained Earnings history

Currency unavailable · from the balance sheet

No Retained Earnings data reported for this period type.

Retained Earnings vs competitors

How SPTX compares with its peers on the latest reported figures

SPTX Competitors
Retained Earnings for SPTX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
LBRXLB Pharmaceuticals Inc Common StockMar 2026-$148.58M USD-29.8%—37.8%
GHRSGH Research PLCMar 2026-$173.23M USD-48.0%—62.9%
CTNMContineum Therapeutics, Inc. Class A Common StockMar 2026-$191.84M USD-43.8%—73.4%
RAPPRapport Therapeutics, Inc. Common StockMar 2026-$255.09M USD-72.6%—51.3%
MPLTMapLight Therapeutics, Inc.Mar 2026-$421.19M USD-90.0%—100.6%
VNDAVanda Pharmaceuticals Inc.Mar 2026-$443.33M USD-117.5%—102.3%
NMRANeumora Therapeutics, Inc. Common StockMar 2026-$1.24B USD-21.9%—804.3%
SPTXSeaport Therapeutics, Inc. Common Stock—— ———
Peer median (excluding SPTX) —-48.0%—73.4%

Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Intrinsic Alpha fair value

Locked

Current Price

$18.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.